Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's ...
Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden. That includes a 20% reciprocal tariff for the ...
Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say ...
Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.
The head of one of America's largest pharmaceutical companies says he does not support tariffs on Australian medicines as US President Donald Trump considers more trade restrictions.
BEIJING - China's reform efforts to promote research and development on medical innovation and shorten the review and ...
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major ...
Eli Lilly’s Mounjaro targets India’s $150 billion weight-loss market amid rising diabetes crisis
Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results